Expand NTHI Menu
NTHI MENU

NTHI Latest Press Releases

-- June 22, 2026 --

International Regulatory Pathways Have Supported Drug Development Across Biotech and Pharma Globe Newswire 9:05 AM

-- June 17, 2026 --

Biotech's New Frontier: Companies Breaking Through Medicine's Toughest Barriers Globe Newswire 10:37 AM
NeOnc's Global Expansion Accelerates After Abu Dhabi IND Approval for NEO212 Globe Newswire 9:18 AM

-- June 16, 2026 --

Wall Street Chases the Next Big Breakout Globe Newswire 3:22 PM
Brain Cancer Innovator NeOnc Heads into Critical Data Season with Fresh Abu Dhabi IND Globe Newswire 1:49 PM
Biotech Bulls Stampede as Clinical Wins and Milestones Fuel Momentum Globe Newswire 10:18 AM
NeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development Globe Newswire 9:00 AM

-- June 12, 2026 --

From Nokia to NeOnc: The Stocks Dominating Screens as Volume Spikes Globe Newswire 11:40 AM

-- June 3, 2026 --

The Multi-Billion-Dollar Search for Better Glioblastoma Treatments Globe Newswire 9:28 AM

-- June 1, 2026 --

Lilly's Cancer Bombshell Sparks Hunt for the Next Oncology Stock Set to Explode Globe Newswire 9:05 AM

-- May 29, 2026 --

The Next Great AI Revolution May Be Drug Delivery Globe Newswire 9:05 AM

-- May 19, 2026 --

NeOnc Technologies Gains Growing Institutional Support Ahead of Key Brain Cancer Clinical Milestones Globe Newswire 10:28 AM

-- May 18, 2026 --

NeOnc Provides Business Update and Reports Q1 2026 Financial Results Globe Newswire 9:00 AM

-- May 7, 2026 --

Biotech's Next Wave May Already be in Motion Globe Newswire 8:45 AM

-- May 6, 2026 --

Where Executives Are Doubling Down on Their Companies' Fortunes Globe Newswire 8:35 AM

-- May 5, 2026 --

NeOnc CEO Accelerates Insider Buying with $500K+ Investment Ahead of Imminent NEO100 Phase 2a Data Catalysts Globe Newswire 9:00 AM

-- April 14, 2026 --

NeOnc Technologies Holdings, Inc. Announces ~ $300,000 in Insider Purchases of NTHI Stock by Chairman and CEO; Company Provides Context on 2025 Financial Results Globe Newswire 9:00 AM

-- April 1, 2026 --

NeOnc Provides Business Update and Reports Q4 2025 Financial Results Globe Newswire 9:00 AM

-- March 13, 2026 --

NeOnc Technologies Appoints David Choi as Chief Accounting Officer Globe Newswire 9:00 AM

-- March 4, 2026 --

NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET Globe Newswire 8:00 AM

-- February 27, 2026 --

NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Dose-Escalation Results from Full Phase 1 NEO212-01 Readout for Dosing and Toxicity Globe Newswire 9:00 AM

-- January 30, 2026 --

NeOnc Technologies Secures Strategic PIPE Investment led by $10 Million Investment from Cinctive Capital Management Globe Newswire 9:00 AM
Market Data Delayed 15 Minutes